Synovus Financial Corp Sage Therapeutics, Inc. Transaction History

Synovus Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$41.13 - $62.45 $1,686 - $2,560	-41 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$25.95 - $43.15 $311 - $517	-12 Reduced 22.64%	41 $2,000
Q1 2020 Apr 24, 2020	BUY	$26.15 - $77.24 $313 - $926	12 Added 29.27%	53 $1,000
Q3 2018 Nov 01, 2018	BUY	$138.11 - $169.04 $5,662 - $6,930	41 New	41 $6,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.